📊 29K iOS Apps Tracked Updated 5 min ago ⚡ Revenue Forecasts
Create Account 🔑 Sign In
Home ⚡ Optimize
52
BU Score
Solid

RxHero - Master Top 250 Drugs

4.0 ✍️ Editor
✍️ bumetric analysis

RxHero - Master Top 250 Drugs is an iOS app from ClinCalc LLC in the Education category, currently rated 4.0★ across 26 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.

Our BU Score puts it at 52: Solid (established niche player). For a Education app, that means established niche player.

Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.

📊 Performance Tracking LIVE

Loading…
idle
0%
Rating
Reviews
Forecast Revenue / mo
Snapshots tracked
0
since first record
Range:

💰 Forecast Revenue / mo

MODEL
Revenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 6 of 6 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
Paid app ($0.00)METRIC
+$2,800
highly recommendREVIEW
+$1,400
Good rating (4.0★)METRIC
+$800
Established app (7y old)METRIC
+$800
Single-language (English only)METRIC
−$400
Pre-traction phase (26 ratings)METRIC
−$300
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)

📈 Reviews Growth

LIVE
Cumulative review count from first BU snapshot. Each point = a tracked update.

⭐ Rating Trend

LIVE
Average rating evolution. Updates with each new review batch.

🗓️ Snapshot Timeline

HISTORY
Each bar shows a tracked update and the metric delta from the previous snapshot.
App Specs
🔐 Own this app? Claim & verify MRR →
💾 33 MB🔞 17+📱 iOS 12.0+🔖 v2.0🔄 updated 5y ago🌐 EN📂 Education💰 Paid🚀 Launched 2019 (7y old)

📝 About this app

RxHero is an educational game for healthcare students and professionals to learn the top 250 medications in the outpatient setting (also known as the Top 200 Drugs or Top 300 Drugs). RxHero uses a multi-modal, adaptive learning approach with quizzes, matching, and drug spelling combined with a gamification component with quests, campaigns, points, and rankings as you progress through the app.

This app is perfect for pharmacists, pharmacy technicians, physician assistants, nurses, nursing students, physicians, medical students, and other healthcare professionals. The drug database is designed to aid in studying for both students in school and those preparing for standardized exams (eg, NAPLEX, BCPS, PTCB, ExCPT, PANCE/PANRE, NCLEX, USMLE, COMLEX).

== FEATURES ==
• Content includes brand/generic names, drug class, indications, common/rare adverse effects, boxed warnings, counseling pearls, notable drug interactions, and mechanism of action
• Assess your drug therapy knowledge using multiple-choice quizzes, term matching, and drug name spelling
• Adaptive (Leitner) learning mode focuses on drug facts that you haven't mastered yet to optimize your study time
• On-demand drug pronunciations are embedded throughout the app
• Contains the top 250 of the most common outpatient medications based on the ClinCalc DrugStats database (version 19.1)

== GAMIFICATION ==
• Motivate your learning with a unique "gamification" component
• Earn points for answering correctly and bonus points for rapid responses
• Earn higher rankings as you accumulate points
• 5-star system denotes your proficiency with each drug category
• Earn a variety of awards as you reach important game milestones in the app

== AUTHOR INFORMATION ==
This app and all of its content was created by Sean P. Kane, PharmD, BCPS – a clinical pharmacist, associate professor, and author of the popular evidence-based website, ClinCalc.com. The drug list and drug information closely mirrors the popular video-based course series The Top 250 Drugs (http://top250drugs.com).

🆕 What's New · v2.0

All users now have access to full drug library; support for newest iOS version + features

Profile & Insights

Everything we know — and don't — about this app and its company.

Identification

App name
RxHero - Master Top 250 Drugs
Developer
ClinCalc LLC
Bundle ID
com.clincalc.rxhero
App Store URL
Open in App Store
Category
Education
Content rating
17+
Languages
EN

Company

Website
clincalc.com
Tagline
Not found
Description
Not found
Founded
Not found
HQ / Address
Not found
Employees
Not found
Logo
Not found

Revenue

Verified revenue / mo
Not found
AI revenue estimate / mo
Not found
AI annual estimate
Not found
ML model estimate / mo
$8.1K/mo
Top-grossing rank
Outside top 99 in US Education
All-time revenue
Not found
Pricing
Not found

Founder

Name
Not found
X / Twitter
Not found
LinkedIn
Not found
GitHub
Not found
X followers
Not found
Public statements
Not found

Funding

Total raised
Not found
Last round
Not found
Investors
Not found
Crunchbase
Not found
AngelList
Not found

Press & Links

Articles found
Not found
Listed on
Not found
Blog
Not found
Press / News
Not found

Contacts & Socials

Socials
Not found
Email
Not found
Phone
Not found
Contact page
Not found
About page
Not found
📈Ratings growth26 ratings+2500% lifetimeShow 3-year history estimate ▾Feb 2020Aug 2024May 2026
Tracked (9 weeks) Pre-tracking estimate (37 weeks) · model-based, ±5% noise · anchored to release date and current value
🌍Geographic ReachNot ranked
This app is currently outside the top 100 grossing in all 9 countries we monitor (US, UK, DE, FR, JP, CA, AU, BR, IN). Niche or new apps often launch this way — popularity rankings appear once daily revenue clears the regional threshold.
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.

More by ClinCalc LLC

View all →

Similar apps in Education

Full revenue analysis
Read the article-style breakdown for RxHero - Master Top 250 Drugs: category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.
Read deep-dive →